Back by popular demand, this fun and exciting game show-style CME program features key opinion leaders (KOLs) as contestants. Hosted by Dr. Sunil K. Srivastava, the final round will feature the winners of the previous two rounds, Drs. J. Michael Jumper & Yoshihiro Yonekawa, battling it out with Dr. Ajay E. Kuriyan!
There will be learning, laughter, and only one KOL left standing!
This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Sunil K. Srivastava, MD
Surgical Retina Fellowship Director
Cleveland Clinic
Cole Eye Institute
Cleveland, OH
J. Michael Jumper, MD, FASRS
West Coast Retina
Vice Chairman
Department of Ophthalmology
California Pacific Medical Center
San Francisco, CA
Ajay E. Kuriyan, MD, MS
Wills Eye Physicians
Mid Atlantic Retina
Associate Professor of Ophthalmology
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Yoshihiro Yonekawa, MD
Associate Professor of Ophthalmology
Wills Eye Hospital, Mid Atlantic Retina
Thomas Jefferson University
Philadelphia, PA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Sunil K. Srivastava, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum Biotechnologies, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Eyevensys, and Novartis. Grant/Research Support: Bausch + Lomb, EyePoint Pharmaceuticals, Eyevensys, and Regeneron.
J. Michael Jumper, MD, FASRS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: EyeBio. Grant/Research Support: Acelyrin, Genentech, and Regenxbio. Shareholder: EyeBio.
Ajay E. Kuriyan, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alimera Sciences, Allergan, Bausch + Lomb, EyePoint Pharmaceuticals, Genentech/Roche, Novartis, Optos, RecensMedical, and Spark Therapeutics. Grant/Research Support: Adverum Biotechnologies, Alcon Research Institute Young Investigator Award, Annexon, Genentech/Roche, Macula Society Young Investigator Award, and Retina Society Research Award. Speaker’s Bureau: Spark Therapeutics and Optos. Stock/Shareholder: RecensMedical.
Yoshihiro Yonekawa, MD,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch Health, EyePoint Pharmaceuticals, Regeneron, and Versant Health. Grant/Research Support: Genentech, Janssen, Kodiak, and Regeneron.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
